Pharmacyte Biotech (PMCB)'s 30-day implied volatility (IV30) was 104.0% at the close on October 16, 2026, up from 99.1% the day before, against a 52-week range of 61.1% to 308.8%. Its 20-day historical volatility was 104.7%.
Data as of October 16, 2026.